Centralized Monitoring: Exploring the Considerations and Challenges of Implementation

Innovaderm's Associate Director - Risk Based Quality Management, Rohit Gupta, contributed to PHUSE's white paper entitled: “Centralized Monitoring: Exploring the Considerations and Challenges of Implementation”.

Innovaderm is proud to have been involved in the development of such a document addressing:

    1. The key success measures & best practices to ensure a well-connected end-to-end component of risk-based quality management;

    2. The positive impact centralized monitoring can have on data quality, patient safety & clinical trial efficiencies;

    3. The current & future needs of holistic central monitoring, the potential early-phase study risk reduction, and decrease of preventable errors.

Reinforce your centralized monitoring knowledge and expertise by reading this white paper now.

Any questions regarding centralized monitoring and risk-based quality management?

Contact us

Get notified to have the latest trends and be at the forefront of dermatology clinical research and innovation.

Subscribe to our newsletter